nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—TOP2A—adrenal gland cancer	0.225	0.779	CbGaD
Doxorubicin—thyroid cancer—adrenal gland cancer	0.139	0.232	CtDrD
Doxorubicin—liver cancer—adrenal gland cancer	0.134	0.224	CtDrD
Doxorubicin—pancreatic cancer—adrenal gland cancer	0.091	0.152	CtDrD
Doxorubicin—testicular cancer—adrenal gland cancer	0.0854	0.142	CtDrD
Doxorubicin—kidney cancer—adrenal gland cancer	0.0762	0.127	CtDrD
Doxorubicin—lung cancer—adrenal gland cancer	0.0735	0.123	CtDrD
Doxorubicin—ABCB1—adrenal gland cancer	0.0639	0.221	CbGaD
Doxorubicin—NOS3—vein—adrenal gland cancer	0.00336	0.0784	CbGeAlD
Doxorubicin—Daunorubicin—NR5A1—adrenal gland cancer	0.00141	0.331	CrCbGaD
Doxorubicin—NOS2—adrenal gland—adrenal gland cancer	0.00136	0.0318	CbGeAlD
Doxorubicin—SLC22A16—gonad—adrenal gland cancer	0.0013	0.0302	CbGeAlD
Doxorubicin—Valrubicin—TOP2A—adrenal gland cancer	0.00119	0.278	CrCbGaD
Doxorubicin—ABCB8—gonad—adrenal gland cancer	0.00101	0.0235	CbGeAlD
Doxorubicin—ABCB8—pituitary gland—adrenal gland cancer	0.000984	0.0229	CbGeAlD
Doxorubicin—AKR1A1—adrenal cortex—adrenal gland cancer	0.000905	0.0211	CbGeAlD
Doxorubicin—ABCB8—adrenal gland—adrenal gland cancer	0.000879	0.0205	CbGeAlD
Doxorubicin—CBR3—adrenal gland—adrenal gland cancer	0.000846	0.0197	CbGeAlD
Doxorubicin—AKR1A1—gonad—adrenal gland cancer	0.00075	0.0175	CbGeAlD
Doxorubicin—AKR1A1—cardiac atrium—adrenal gland cancer	0.000749	0.0175	CbGeAlD
Doxorubicin—AKR1A1—pituitary gland—adrenal gland cancer	0.000731	0.0171	CbGeAlD
Doxorubicin—Idarubicin—TOP2A—adrenal gland cancer	0.000683	0.16	CrCbGaD
Doxorubicin—NDUFS2—adrenal cortex—adrenal gland cancer	0.000682	0.0159	CbGeAlD
Doxorubicin—NDUFS7—cardiac atrium—adrenal gland cancer	0.00068	0.0159	CbGeAlD
Doxorubicin—NDUFS3—adrenal cortex—adrenal gland cancer	0.000673	0.0157	CbGeAlD
Doxorubicin—AKR1A1—adrenal gland—adrenal gland cancer	0.000653	0.0152	CbGeAlD
Doxorubicin—DHCR7—adrenal cortex—adrenal gland cancer	0.00064	0.0149	CbGeAlD
Doxorubicin—AURKA—gonad—adrenal gland cancer	0.000633	0.0148	CbGeAlD
Doxorubicin—AURKA—pituitary gland—adrenal gland cancer	0.000618	0.0144	CbGeAlD
Doxorubicin—NDUFS7—adrenal gland—adrenal gland cancer	0.000594	0.0138	CbGeAlD
Doxorubicin—YWHAG—adrenal cortex—adrenal gland cancer	0.000587	0.0137	CbGeAlD
Doxorubicin—NOS1—gonad—adrenal gland cancer	0.000568	0.0132	CbGeAlD
Doxorubicin—NDUFS2—gonad—adrenal gland cancer	0.000565	0.0132	CbGeAlD
Doxorubicin—NDUFS2—cardiac atrium—adrenal gland cancer	0.000564	0.0131	CbGeAlD
Doxorubicin—NDUFS3—gonad—adrenal gland cancer	0.000558	0.013	CbGeAlD
Doxorubicin—NDUFS3—cardiac atrium—adrenal gland cancer	0.000557	0.013	CbGeAlD
Doxorubicin—AURKA—adrenal gland—adrenal gland cancer	0.000552	0.0129	CbGeAlD
Doxorubicin—NDUFS2—pituitary gland—adrenal gland cancer	0.000551	0.0128	CbGeAlD
Doxorubicin—CYP3A4—urine—adrenal gland cancer	0.000545	0.0127	CbGeAlD
Doxorubicin—NDUFS3—pituitary gland—adrenal gland cancer	0.000544	0.0127	CbGeAlD
Doxorubicin—CYP2D6—urine—adrenal gland cancer	0.000537	0.0125	CbGeAlD
Doxorubicin—RALBP1—adrenal cortex—adrenal gland cancer	0.00053	0.0124	CbGeAlD
Doxorubicin—DHCR7—gonad—adrenal gland cancer	0.00053	0.0124	CbGeAlD
Doxorubicin—DHCR7—cardiac atrium—adrenal gland cancer	0.000529	0.0123	CbGeAlD
Doxorubicin—Epirubicin—TOP2A—adrenal gland cancer	0.000518	0.121	CrCbGaD
Doxorubicin—DHCR7—pituitary gland—adrenal gland cancer	0.000517	0.0121	CbGeAlD
Doxorubicin—CBR1—adrenal cortex—adrenal gland cancer	0.000495	0.0115	CbGeAlD
Doxorubicin—NDUFS2—adrenal gland—adrenal gland cancer	0.000492	0.0115	CbGeAlD
Doxorubicin—AKR1C3—adrenal cortex—adrenal gland cancer	0.000489	0.0114	CbGeAlD
Doxorubicin—YWHAG—gonad—adrenal gland cancer	0.000486	0.0113	CbGeAlD
Doxorubicin—NDUFS3—adrenal gland—adrenal gland cancer	0.000486	0.0113	CbGeAlD
Doxorubicin—YWHAG—cardiac atrium—adrenal gland cancer	0.000486	0.0113	CbGeAlD
Doxorubicin—YWHAG—pituitary gland—adrenal gland cancer	0.000474	0.0111	CbGeAlD
Doxorubicin—DHCR7—adrenal gland—adrenal gland cancer	0.000462	0.0108	CbGeAlD
Doxorubicin—POR—adrenal cortex—adrenal gland cancer	0.000446	0.0104	CbGeAlD
Doxorubicin—RALBP1—cardiac atrium—adrenal gland cancer	0.000438	0.0102	CbGeAlD
Doxorubicin—RALBP1—pituitary gland—adrenal gland cancer	0.000428	0.00999	CbGeAlD
Doxorubicin—YWHAG—adrenal gland—adrenal gland cancer	0.000424	0.00988	CbGeAlD
Doxorubicin—CBR1—gonad—adrenal gland cancer	0.00041	0.00956	CbGeAlD
Doxorubicin—CBR1—cardiac atrium—adrenal gland cancer	0.000409	0.00954	CbGeAlD
Doxorubicin—AKR1C3—cardiac atrium—adrenal gland cancer	0.000404	0.00943	CbGeAlD
Doxorubicin—CBR1—pituitary gland—adrenal gland cancer	0.0004	0.00932	CbGeAlD
Doxorubicin—NQO1—adrenal cortex—adrenal gland cancer	0.000396	0.00925	CbGeAlD
Doxorubicin—AKR1C3—pituitary gland—adrenal gland cancer	0.000395	0.00921	CbGeAlD
Doxorubicin—RALBP1—adrenal gland—adrenal gland cancer	0.000383	0.00892	CbGeAlD
Doxorubicin—NOS3—adrenal gland—adrenal gland cancer	0.000376	0.00878	CbGeAlD
Doxorubicin—POR—cardiac atrium—adrenal gland cancer	0.000369	0.00861	CbGeAlD
Doxorubicin—Daunorubicin—TOP2A—adrenal gland cancer	0.000366	0.0857	CrCbGaD
Doxorubicin—POR—pituitary gland—adrenal gland cancer	0.000361	0.00841	CbGeAlD
Doxorubicin—CBR1—adrenal gland—adrenal gland cancer	0.000357	0.00833	CbGeAlD
Doxorubicin—ABCC3—adrenal cortex—adrenal gland cancer	0.000356	0.0083	CbGeAlD
Doxorubicin—ABCC10—adrenal cortex—adrenal gland cancer	0.000354	0.00826	CbGeAlD
Doxorubicin—AKR1C3—adrenal gland—adrenal gland cancer	0.000353	0.00823	CbGeAlD
Doxorubicin—POR—adrenal gland—adrenal gland cancer	0.000322	0.00751	CbGeAlD
Doxorubicin—NQO1—pituitary gland—adrenal gland cancer	0.00032	0.00747	CbGeAlD
Doxorubicin—TOP2A—adrenal gland—adrenal gland cancer	0.0003	0.007	CbGeAlD
Doxorubicin—ABCC10—gonad—adrenal gland cancer	0.000293	0.00684	CbGeAlD
Doxorubicin—ABCC10—cardiac atrium—adrenal gland cancer	0.000293	0.00683	CbGeAlD
Doxorubicin—NQO1—adrenal gland—adrenal gland cancer	0.000286	0.00667	CbGeAlD
Doxorubicin—ABCC10—pituitary gland—adrenal gland cancer	0.000286	0.00667	CbGeAlD
Doxorubicin—ABCC3—adrenal gland—adrenal gland cancer	0.000257	0.00599	CbGeAlD
Doxorubicin—ABCC10—adrenal gland—adrenal gland cancer	0.000256	0.00596	CbGeAlD
Doxorubicin—ABCC1—adrenal cortex—adrenal gland cancer	0.00025	0.00584	CbGeAlD
Doxorubicin—CYP1B1—gonad—adrenal gland cancer	0.000231	0.00538	CbGeAlD
Doxorubicin—CYP1B1—pituitary gland—adrenal gland cancer	0.000225	0.00525	CbGeAlD
Doxorubicin—ABCG2—adrenal cortex—adrenal gland cancer	0.000207	0.00483	CbGeAlD
Doxorubicin—ABCC1—cardiac atrium—adrenal gland cancer	0.000207	0.00483	CbGeAlD
Doxorubicin—ABCC2—adrenal gland—adrenal gland cancer	0.000205	0.00479	CbGeAlD
Doxorubicin—ABCC1—pituitary gland—adrenal gland cancer	0.000202	0.00472	CbGeAlD
Doxorubicin—CYP1B1—adrenal gland—adrenal gland cancer	0.000201	0.00469	CbGeAlD
Doxorubicin—CYP2B6—adrenal cortex—adrenal gland cancer	0.000191	0.00446	CbGeAlD
Doxorubicin—ABCC1—adrenal gland—adrenal gland cancer	0.000181	0.00422	CbGeAlD
Doxorubicin—ABCG2—pituitary gland—adrenal gland cancer	0.000168	0.00391	CbGeAlD
Doxorubicin—CYP2B6—gonad—adrenal gland cancer	0.000158	0.00369	CbGeAlD
Doxorubicin—ABCG2—adrenal gland—adrenal gland cancer	0.00015	0.00349	CbGeAlD
Doxorubicin—CYP2B6—adrenal gland—adrenal gland cancer	0.000138	0.00322	CbGeAlD
Doxorubicin—Daunorubicin—ABCB1—adrenal gland cancer	0.000104	0.0244	CrCbGaD
Doxorubicin—ABCB1—adrenal cortex—adrenal gland cancer	0.000102	0.00238	CbGeAlD
Doxorubicin—ABCB1—gonad—adrenal gland cancer	8.47e-05	0.00197	CbGeAlD
Doxorubicin—ABCB1—pituitary gland—adrenal gland cancer	8.26e-05	0.00193	CbGeAlD
Doxorubicin—ABCB1—adrenal gland—adrenal gland cancer	7.38e-05	0.00172	CbGeAlD
Doxorubicin—CYP1B1—Metabolism—SDHB—adrenal gland cancer	2.3e-05	0.000354	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—ABCB1—adrenal gland cancer	2.29e-05	0.000352	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.27e-05	0.000349	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ZNRF3—adrenal gland cancer	2.27e-05	0.000349	CbGpPWpGaD
Doxorubicin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	2.25e-05	0.000345	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—MED12—adrenal gland cancer	2.22e-05	0.000341	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MEN1—adrenal gland cancer	2.14e-05	0.000329	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—RB1—adrenal gland cancer	2.13e-05	0.000326	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—GNRH1—adrenal gland cancer	2.12e-05	0.000325	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—POMC—adrenal gland cancer	2.11e-05	0.000324	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—POMC—adrenal gland cancer	2.11e-05	0.000324	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PRKACA—adrenal gland cancer	2.11e-05	0.000323	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SDHB—adrenal gland cancer	2.1e-05	0.000322	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	2.09e-05	0.000321	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CDC42—adrenal gland cancer	2.08e-05	0.000319	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—MED12—adrenal gland cancer	2.07e-05	0.000317	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—SDHD—adrenal gland cancer	2.04e-05	0.000314	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—RRM1—adrenal gland cancer	2.04e-05	0.000314	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	2e-05	0.000307	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IGF2—adrenal gland cancer	2e-05	0.000307	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.99e-05	0.000305	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—GNAS—adrenal gland cancer	1.98e-05	0.000304	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—POMC—adrenal gland cancer	1.98e-05	0.000304	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—SDHD—adrenal gland cancer	1.96e-05	0.000301	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—RRM1—adrenal gland cancer	1.96e-05	0.000301	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SPRY2—adrenal gland cancer	1.94e-05	0.000298	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PRKACA—adrenal gland cancer	1.94e-05	0.000297	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IGF1R—adrenal gland cancer	1.93e-05	0.000297	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TERT—adrenal gland cancer	1.91e-05	0.000293	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TERT—adrenal gland cancer	1.9e-05	0.000292	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TSHR—adrenal gland cancer	1.89e-05	0.00029	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—MED12—adrenal gland cancer	1.88e-05	0.000288	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.87e-05	0.000288	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—CDKN2A—adrenal gland cancer	1.87e-05	0.000287	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.84e-05	0.000283	CbGpPWpGaD
Doxorubicin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	1.81e-05	0.000278	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.81e-05	0.000278	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.81e-05	0.000278	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.8e-05	0.000277	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GNRH1—adrenal gland cancer	1.79e-05	0.000275	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CDC42—adrenal gland cancer	1.79e-05	0.000274	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.78e-05	0.000274	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MEN1—adrenal gland cancer	1.78e-05	0.000273	CbGpPWpGaD
Doxorubicin—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	1.72e-05	0.000264	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—POMC—adrenal gland cancer	1.68e-05	0.000259	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PRKACA—adrenal gland cancer	1.68e-05	0.000258	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PTGS2—adrenal gland cancer	1.68e-05	0.000258	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PTGS2—adrenal gland cancer	1.68e-05	0.000258	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.68e-05	0.000258	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TERT—adrenal gland cancer	1.66e-05	0.000256	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—RB1—adrenal gland cancer	1.66e-05	0.000255	CbGpPWpGaD
Doxorubicin—NOS1—Disease—BAD—adrenal gland cancer	1.65e-05	0.000254	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CDC42—adrenal gland cancer	1.64e-05	0.000252	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SPRY2—adrenal gland cancer	1.64e-05	0.000251	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PRKACA—adrenal gland cancer	1.64e-05	0.000251	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PRKACA—adrenal gland cancer	1.62e-05	0.000249	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—adrenal gland cancer	1.61e-05	0.000248	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TSHR—adrenal gland cancer	1.6e-05	0.000245	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.58e-05	0.000243	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PTGS2—adrenal gland cancer	1.58e-05	0.000243	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—POMC—adrenal gland cancer	1.57e-05	0.000241	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.57e-05	0.000241	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SDHB—adrenal gland cancer	1.54e-05	0.000236	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—RRM1—adrenal gland cancer	1.53e-05	0.000236	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—SDHD—adrenal gland cancer	1.53e-05	0.000236	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—MED12—adrenal gland cancer	1.52e-05	0.000234	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PRKACA—adrenal gland cancer	1.51e-05	0.000231	CbGpPWpGaD
Doxorubicin—NOS1—Disease—BRAF—adrenal gland cancer	1.51e-05	0.000231	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MEN1—adrenal gland cancer	1.5e-05	0.00023	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—adrenal gland cancer	1.49e-05	0.000229	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—RB1—adrenal gland cancer	1.49e-05	0.000228	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—RRM1—adrenal gland cancer	1.48e-05	0.000228	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—SDHD—adrenal gland cancer	1.48e-05	0.000228	CbGpPWpGaD
Doxorubicin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	1.47e-05	0.000226	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.46e-05	0.000224	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	1.46e-05	0.000224	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—MED12—adrenal gland cancer	1.46e-05	0.000224	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—BAD—adrenal gland cancer	1.45e-05	0.000222	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.44e-05	0.000222	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.43e-05	0.00022	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TERT—adrenal gland cancer	1.43e-05	0.00022	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SPRY2—adrenal gland cancer	1.43e-05	0.000219	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.42e-05	0.000218	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CDC42—adrenal gland cancer	1.39e-05	0.000213	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—adrenal gland cancer	1.37e-05	0.000211	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PRKACA—adrenal gland cancer	1.37e-05	0.00021	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GNAS—adrenal gland cancer	1.36e-05	0.000209	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.36e-05	0.000209	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PRKACA—adrenal gland cancer	1.36e-05	0.000208	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SDHD—adrenal gland cancer	1.35e-05	0.000207	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—RRM1—adrenal gland cancer	1.35e-05	0.000207	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PTGS2—adrenal gland cancer	1.34e-05	0.000206	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ABCB1—adrenal gland cancer	1.34e-05	0.000205	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—POMC—adrenal gland cancer	1.34e-05	0.000205	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—BRAF—adrenal gland cancer	1.32e-05	0.000202	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TERT—adrenal gland cancer	1.32e-05	0.000202	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GNAS—adrenal gland cancer	1.31e-05	0.000202	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDKN2A—adrenal gland cancer	1.31e-05	0.000201	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MEN1—adrenal gland cancer	1.31e-05	0.000201	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.31e-05	0.0002	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ABCB1—adrenal gland cancer	1.29e-05	0.000198	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.27e-05	0.000195	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	1.26e-05	0.000194	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTGS2—adrenal gland cancer	1.25e-05	0.000192	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.25e-05	0.000192	CbGpPWpGaD
Doxorubicin—NOS2—Disease—BAD—adrenal gland cancer	1.25e-05	0.000191	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GNAS—adrenal gland cancer	1.22e-05	0.000188	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PTGS2—adrenal gland cancer	1.22e-05	0.000187	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ABCB1—adrenal gland cancer	1.2e-05	0.000184	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	1.19e-05	0.000183	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CDC42—adrenal gland cancer	1.15e-05	0.000177	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—BAD—adrenal gland cancer	1.15e-05	0.000176	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PRKACA—adrenal gland cancer	1.15e-05	0.000176	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—MED12—adrenal gland cancer	1.14e-05	0.000176	CbGpPWpGaD
Doxorubicin—NOS2—Disease—BRAF—adrenal gland cancer	1.14e-05	0.000174	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SDHB—adrenal gland cancer	1.13e-05	0.000174	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—adrenal gland cancer	1.13e-05	0.000173	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TERT—adrenal gland cancer	1.11e-05	0.000171	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PRKACA—adrenal gland cancer	1.11e-05	0.000171	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GNAS—adrenal gland cancer	1.11e-05	0.00017	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IGF2—adrenal gland cancer	1.11e-05	0.00017	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—MED12—adrenal gland cancer	1.11e-05	0.00017	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—GNAS—adrenal gland cancer	1.1e-05	0.000169	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ABCB1—adrenal gland cancer	1.09e-05	0.000167	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CTNNB1—adrenal gland cancer	1.09e-05	0.000167	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.09e-05	0.000167	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IGF1R—adrenal gland cancer	1.07e-05	0.000165	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SDHB—adrenal gland cancer	1.07e-05	0.000164	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PRKACA—adrenal gland cancer	1.07e-05	0.000164	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—BRAF—adrenal gland cancer	1.04e-05	0.00016	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.04e-05	0.00016	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—adrenal gland cancer	1.04e-05	0.00016	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.02e-05	0.000157	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MED12—adrenal gland cancer	1.01e-05	0.000155	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PRKACA—adrenal gland cancer	9.97e-06	0.000153	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SDHD—adrenal gland cancer	9.9e-06	0.000152	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—RRM1—adrenal gland cancer	9.9e-06	0.000152	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	9.89e-06	0.000152	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDC42—adrenal gland cancer	9.72e-06	0.000149	CbGpPWpGaD
Doxorubicin—NOS3—Disease—BAD—adrenal gland cancer	9.68e-06	0.000149	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CTNNB1—adrenal gland cancer	9.53e-06	0.000146	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IGF2—adrenal gland cancer	9.36e-06	0.000144	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	9.29e-06	0.000143	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GNAS—adrenal gland cancer	9.28e-06	0.000143	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TERT—adrenal gland cancer	9.22e-06	0.000142	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—POMC—adrenal gland cancer	9.17e-06	0.000141	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTGS2—adrenal gland cancer	9.17e-06	0.000141	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IGF1R—adrenal gland cancer	9.05e-06	0.000139	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GNAS—adrenal gland cancer	9.01e-06	0.000138	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—POMC—adrenal gland cancer	8.85e-06	0.000136	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ABCB1—adrenal gland cancer	8.84e-06	0.000136	CbGpPWpGaD
Doxorubicin—NOS3—Disease—BRAF—adrenal gland cancer	8.81e-06	0.000135	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—adrenal gland cancer	8.75e-06	0.000134	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GNAS—adrenal gland cancer	8.63e-06	0.000133	CbGpPWpGaD
Doxorubicin—NOS1—Disease—EGFR—adrenal gland cancer	8.62e-06	0.000132	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	8.48e-06	0.00013	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ABCB1—adrenal gland cancer	8.47e-06	0.00013	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDC42—adrenal gland cancer	8.45e-06	0.00013	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTGS2—adrenal gland cancer	8.43e-06	0.000129	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PRKACA—adrenal gland cancer	8.35e-06	0.000128	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	8.32e-06	0.000128	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—POMC—adrenal gland cancer	8.23e-06	0.000126	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CTNNB1—adrenal gland cancer	8.2e-06	0.000126	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	8.16e-06	0.000125	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PRKACA—adrenal gland cancer	8.07e-06	0.000124	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—BAD—adrenal gland cancer	8.02e-06	0.000123	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	7.89e-06	0.000121	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	7.81e-06	0.00012	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TERT—adrenal gland cancer	7.79e-06	0.00012	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EGFR—adrenal gland cancer	7.55e-06	0.000116	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CTNNB1—adrenal gland cancer	7.54e-06	0.000116	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—POMC—adrenal gland cancer	7.48e-06	0.000115	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—POMC—adrenal gland cancer	7.4e-06	0.000114	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MED12—adrenal gland cancer	7.38e-06	0.000113	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PRKACA—adrenal gland cancer	7.35e-06	0.000113	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGS2—adrenal gland cancer	7.31e-06	0.000112	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—BRAF—adrenal gland cancer	7.31e-06	0.000112	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—RRM1—adrenal gland cancer	7.3e-06	0.000112	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SDHD—adrenal gland cancer	7.3e-06	0.000112	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—adrenal gland cancer	7.27e-06	0.000112	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTGS2—adrenal gland cancer	7.12e-06	0.000109	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—adrenal gland cancer	7.06e-06	0.000108	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SDHB—adrenal gland cancer	6.98e-06	0.000107	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—RRM1—adrenal gland cancer	6.88e-06	0.000106	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SDHD—adrenal gland cancer	6.88e-06	0.000106	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	6.87e-06	0.000106	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TERT—adrenal gland cancer	6.78e-06	0.000104	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—BAD—adrenal gland cancer	6.78e-06	0.000104	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GNAS—adrenal gland cancer	6.77e-06	0.000104	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ABCB1—adrenal gland cancer	6.64e-06	0.000102	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	6.59e-06	0.000101	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—adrenal gland cancer	6.56e-06	0.000101	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GNAS—adrenal gland cancer	6.54e-06	0.0001	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EGFR—adrenal gland cancer	6.5e-06	9.98e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ABCB1—adrenal gland cancer	6.42e-06	9.86e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CTNNB1—adrenal gland cancer	6.37e-06	9.78e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—adrenal gland cancer	6.34e-06	9.73e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—POMC—adrenal gland cancer	6.25e-06	9.6e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—BRAF—adrenal gland cancer	6.17e-06	9.48e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—POMC—adrenal gland cancer	6.06e-06	9.31e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EGFR—adrenal gland cancer	5.97e-06	9.17e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—adrenal gland cancer	5.96e-06	9.16e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GNAS—adrenal gland cancer	5.95e-06	9.14e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—BAD—adrenal gland cancer	5.9e-06	9.06e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ABCB1—adrenal gland cancer	5.84e-06	8.97e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—POMC—adrenal gland cancer	5.81e-06	8.93e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	5.53e-06	8.49e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MED12—adrenal gland cancer	5.44e-06	8.36e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	5.38e-06	8.27e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—BRAF—adrenal gland cancer	5.37e-06	8.25e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CTNNB1—adrenal gland cancer	5.28e-06	8.11e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MED12—adrenal gland cancer	5.13e-06	7.88e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EGFR—adrenal gland cancer	5.05e-06	7.75e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—adrenal gland cancer	4.84e-06	7.43e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—adrenal gland cancer	4.64e-06	7.12e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—POMC—adrenal gland cancer	4.56e-06	6.99e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SDHD—adrenal gland cancer	4.5e-06	6.91e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—RRM1—adrenal gland cancer	4.5e-06	6.91e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CTNNB1—adrenal gland cancer	4.46e-06	6.85e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—POMC—adrenal gland cancer	4.41e-06	6.77e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GNAS—adrenal gland cancer	4.36e-06	6.7e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—adrenal gland cancer	4.34e-06	6.66e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	4.28e-06	6.58e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EGFR—adrenal gland cancer	4.18e-06	6.42e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—POMC—adrenal gland cancer	4.01e-06	6.16e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PRKACA—adrenal gland cancer	3.97e-06	6.1e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CTNNB1—adrenal gland cancer	3.88e-06	5.96e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	3.74e-06	5.75e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—adrenal gland cancer	3.63e-06	5.58e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EGFR—adrenal gland cancer	3.53e-06	5.43e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—adrenal gland cancer	3.51e-06	5.4e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—adrenal gland cancer	3.51e-06	5.39e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MED12—adrenal gland cancer	3.35e-06	5.15e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GNAS—adrenal gland cancer	3.22e-06	4.94e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—adrenal gland cancer	3.2e-06	4.91e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EGFR—adrenal gland cancer	3.08e-06	4.72e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GNAS—adrenal gland cancer	3.03e-06	4.66e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	2.98e-06	4.57e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—adrenal gland cancer	2.97e-06	4.56e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—POMC—adrenal gland cancer	2.94e-06	4.51e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	2.45e-06	3.76e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	2.34e-06	3.6e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—POMC—adrenal gland cancer	2.17e-06	3.33e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—POMC—adrenal gland cancer	2.04e-06	3.14e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.98e-06	3.05e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.95e-06	2.99e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.73e-06	2.65e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.63e-06	2.5e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.34e-06	2.05e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	1.06e-06	1.64e-05	CbGpPWpGaD
